Senhwa Biosciences Inc(TW:6492)
NT$30.100.00 (0.00%)
TW:6492
Senhwa Biosciences Inc financials statements
NT$30.10
At close:0.00 (0.00%)
Senhwa Biosciences Inc (6492) Ratios
Senhwa Biosciences Inc Ratios
TW:6492's free cash flow for Q2 2026 was NT$-49.46M. For the 2026 fiscal year, TW:6492's free cash flow was decreased by NT$-228.00K and operating cash flow was NT$-49.23M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 17.21 | 33.29 | 31.40 | 49.69 | 24.87 |
| Quick Ratio | 17.21 | 33.29 | 31.40 | 49.69 | 24.87 |
| Cash Ratio | 17.02 | 33.00 | 30.75 | 49.14 | 24.72 |
| Solvency Ratio | -4.33 | -7.24 | -6.18 | -8.37 | -3.49 |
| Operating Cash Flow Ratio | -5.48 | -9.46 | -6.68 | -12.14 | -3.65 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 722.11M | NT$ 995.91M | NT$ 1.30B | NT$ 1.60B | NT$ 1.95B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.08 | 1.04 | 1.04 | 1.03 | 1.05 |
| Debt Service Coverage Ratio | -355.22 | -423.81 | -532.80 | -628.63 | -613.11 |
| Interest Coverage Ratio | -369.53 | -461.83 | -581.52 | -654.62 | -658.40 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.26 | 0.18 | 0.11 | 0.19 | 0.18 |
| Net Debt to EBITDA | 2.82 | 3.61 | 4.61 | 4.71 | 6.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.60% | 47.70% | 55.20% | -660.70% | -1074.73% |
| EBIT Margin | -26005.51% | -29180.10% | -29451.00% | -34771.60% | -59603.82% |
| EBITDA Margin | -24873.93% | -27970.60% | -28378.50% | -34060.40% | -58470.36% |
| Operating Profit Margin | -26005.51% | -30619.10% | -31111.10% | -35611.50% | -62966.55% |
| Pretax Profit Margin | -24620.19% | -29246.40% | -29504.50% | -34826.00% | -59699.45% |
| Net Profit Margin | -24744.77% | -29374.50% | -29630.60% | -34963.20% | -59864.91% |
| Continuous Operations Profit Margin | -24744.77% | -29374.50% | -29630.60% | -34963.20% | -59864.91% |
| Net Income Per EBT | 100.51% | 100.44% | 100.43% | 100.39% | 100.28% |
| EBT Per EBIT | 94.67% | 95.52% | 94.84% | 97.79% | 94.81% |
| Return on Assets (ROA) | -32.32% | -27.56% | -21.73% | -21.13% | -15.97% |
| Return on Equity (ROE) | -34.79% | -28.60% | -22.50% | -21.66% | -16.72% |
| Return on Capital Employed (ROCE) | -35.95% | -29.59% | -23.56% | -21.96% | -17.50% |
| Return on Invested Capital (ROIC) | -35.53% | -29.38% | -23.45% | -21.85% | -17.45% |
| Return on Tangible Assets | -32.32% | -27.56% | -21.74% | -21.13% | -15.97% |
| Earnings Yield | -6.75% | -7.57% | -6.57% | -6.76% | -3.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.64 | 5.49 | 0.09 | 1.76 | 1.21 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.05 | 0.06 | 0.07 | 0.06 | 0.04 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 47.76 | 66.43 | 3866.45 | 207.69 | 302.62 |
| Days of Sales Outstanding | 47.76 | 66.43 | 3866.45 | 207.69 | 302.62 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 47.76 | 66.43 | 3866.45 | 207.69 | 302.62 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.79 | -3.30 | -3.21 | -4.48 | -3.35 |
| Free Cash Flow Per Share | -2.79 | -3.32 | -3.26 | -4.49 | -3.35 |
| Dividend Paid and CapEx Coverage Ratio | -887.35 | -150.57 | -59.98 | -1083.93 | -748.25 |
| Capital Expenditure Coverage Ratio | -887.35 | -150.57 | -59.98 | -1083.93 | -748.25 |
| Operating Cash Flow Coverage Ratio | -11.23 | -19.62 | -29.83 | -24.75 | -19.51 |
| Operating Cash Flow to Sales Ratio | -232.20 | -294.22 | -286.35 | -399.97 | -545.55 |
| Free Cash Flow Yield | -6.34% | -7.63% | -6.45% | -7.74% | -3.22% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.81 | -13.22 | -15.24 | -14.80 | -28.34 |
| Price-to-Sales (P/S) Ratio | 3665.90 | 3879.59 | 4512.81 | 5173.02 | 16950.49 |
| Price-to-Book (P/B) Ratio | 5.15 | 3.78 | 3.43 | 3.21 | 4.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.77 | -13.10 | -15.50 | -12.92 | -31.03 |
| Price-to-Operating Cash Flow Ratio | -15.79 | -13.19 | -15.76 | -12.93 | -31.07 |
| Price-to-Earnings Growth (PEG) Ratio | 1.52 | 14.63 | 1.00 | -2.17 | 1.55 |
| Enterprise Value Multiple | -11.92 | -10.26 | -11.29 | -10.48 | -22.72 |
| Enterprise Value | 3.17B | 2.87B | 3.20B | 3.57B | 7.31B |
| EV to EBITDA | -11.92 | -10.26 | -11.29 | -10.48 | -22.72 |
| EV to Sales | 2965.28 | 2868.62 | 3203.60 | 3570.04 | 13282.85 |
| EV to Free Cash Flow | -12.76 | -9.69 | -11.00 | -8.92 | -24.32 |
| EV to Operating Cash Flow | -12.77 | -9.75 | -11.19 | -8.93 | -24.35 |
| Tangible Book Value Per Share | 8.54 | 11.51 | 14.77 | 18.10 | 21.97 |
| Shareholders’ Equity Per Share | 8.54 | 11.52 | 14.77 | 18.10 | 21.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Income Per Share | -2.97 | -3.29 | -3.32 | -3.92 | -3.67 |
| Tax Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.95 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 203.50 | 243.74 | 256.87 | 312.85 | 500.85 |
| SG&A to Revenue | 45.72 | 62.93 | 54.79 | 36.66 | 118.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | -0.64 | 1.03 | 6.31 |
| Income Quality | 0.94 | 1.01 | 0.97 | 1.14 | 0.91 |
Currency in TWD
